BASTION – Phase II Trial of BrECADD in HIV-Positive Patients with Advanced-Stage Classic Hodgkin Lymphoma
Sponsor: University Of Cologne
Phase: 2
Disease: Advanced-stage classic Hodgkin lymphoma
EU trial number: 2025-521749-26-00
Population: Adults aged 18–75 years with previously untreated, histologically confirmed advanced-stage classic Hodgkin lymphoma and HIV infection, CD4 count of at least 50/µL, ECOG performance status 0–1, and mandatory ongoing or initiated antiretroviral therapy.
Register Investigator Interest
Interested in offering this trial to suitable patients?